2. Search Result
Search Result
Results for "

cholecystokinin

" in MedChemExpress (MCE) Product Catalog:

37

Inhibitors & Agonists

25

Peptides

1

Natural
Products

1

Recombinant Proteins

Cat. No. Product Name Target Research Area
  • HY-P2932
    Cholecystokinin

    cholecystokinin-33(human); CCK-33(human)

    		 Peptides Metabolic Disease
    Cholecystokinin is a peptide hormone. Cholecystokinin, as a hunger suppressant, inhibits food intake and stimulates the digestion of fat and protein. Cholecystokinin can be used for the research of gastrointestinal system .
  • HY-P3651
    Cholecystokinin (26-33) (free acid)

    CCK (26-33) (free acid)

    		 Peptides Metabolic Disease
    Cholecystokinin (26-33) (CCK (26-33)) free acid is a cholecystokinin (CCK) fragment. Cholecystokinin (26-33) free acid can reduce food intake and gallbladder contraction .
  • HY-P2636
    Cholecystokinin Precursor (24-32) (rat)

    Prepro CCK Fragment V-9-M

    		 Peptides Metabolic Disease
    Cholecystokinin Precursor (24-32) (rat) is a cholecystokinin precursor that can be expressed in the heart, lungs, and kidneys as well as in the gastrointestinal tract and brain. Cholecystokinin is a brain-gut peptide that stimulates gallbladder contraction and pancreatic exocrine secretion and also acts as a neurotransmitter .
  • HY-P3652
    Cholecystokinin-33 (swine)

    		Peptides Metabolic Disease
    Cholecystokinin-33 (swine) is a cholecystokinin (CCK) fragment. Cholecystokinin-33 (swine) can reduce food intake and gallbladder contraction .
  • HY-P3650
    Cholecystokinin (1-21)

    CCK-1-21

    		 Peptides Metabolic Disease
    Cholecystokinin (1-21) (CCK-1-21) is a cholecystokinin (CCK) fragment. Cholecystokinin (1-21) stimulates lipolysis in human adipose tissue .
  • HY-P2932A
    Cholecystokinin-33 free acid

    		Peptides Neurological Disease
    Cholecystokinin-33 free acid is an analogue of Cholecystokinin (HY-P2932). C-terminal amidation is important for binding of Cholecystokinin to its receptors, and removing the amide group would decrease Cholecystokinin activity. Cholecystokinin-33 free acid can be used to study C-terminal amidation of Cholecystokinin-33 .
  • HY-P0196A
    Cholecystokinin Octapeptide, desulfated TFA
    2 Publications Verification

    CCK Octapeptide, desulfated TFA

    		 Peptides Metabolic Disease
    Cholecystokinin Octapeptide, desulfated TFA is a synthetic desulfated octapeptides of Cholecystokinin (CCK) .
  • HY-125556
    Tetragastrin

    cholecystokinin tetrapeptide; CCK-4

    		 Cholecystokinin Receptor Metabolic Disease
    Tetragastrin (Cholecystokinin tetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin. Tetragastrin can stimulate gastric secretion . Tetragastrin is a Cholecystokinin (CCK-4) receptor agonist . Gastric mucosal protection .
  • HY-P0093A
    Sincalide ammonium
    3 Publications Verification

    cholecystokinin octapeptide ammonium; CCK-8 ammonium; SQ19844 ammonium

    		 Cholecystokinin Receptor Apoptosis PI3K Akt Infection Cancer
    Sincalide ammonium (Cholecystokinin octapeptide ammonium, CCK-8 ammonium) is a rapid-acting amino acid polypeptide hormone analogue of cholecystokinin (CCK) for intravenous use in postevacuation cholecystography. Sincalide ammonium is a major bioactive segment of CCK that retains most of the biological activities of CCK. CCK‐8 can promote gallbladder contraction by injection and helps diagnose gallbladder and pancreas disorders. Sincalide ammonium can increase bile secretion, cause the gallbladder to contract and relax the sphincter of Oddi, resulting in bile drainage into the duodenum. Sincalide ammonium is a major bioactive segment of CCK that retains most of the biological activities of CCK .
  • HY-P5000
    Cholecystokinin Octapeptide (1-2) (desulfated)

    H-Asp-Tyr-OH

    		 Peptides Others
    Cholecystokinin Octapeptide (1-2) (desulfated) (H-Asp-Tyr-OH) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development .
  • HY-P10063
    Cionin

    		Peptides Metabolic Disease
    Cionin is a disulfotyrosyl hybrid of cholecystokinin and gastrin .
  • HY-P5519
    [Thr28, Nle31]-Cholecystokinin (25-33), sulfated

    		Peptides Others
    [Thr28, Nle31]-Cholecystokinin (25-33) is a biological active peptide. (Cholecystokinin (CCK) acts both as a hormone and a neurotransmitter and is found in the GI system and the central nervous system. It is a satiety peptide that inhibits food intake.This Cholecystokinin (CCK) analog retains all the bioactivities of CCK8, but was found to be remarkably more stable in acidic media and unaffected by air oxidation due to Met replacements (Thr 28 and Nle31 were substituted for Methionine). The predominant conformation contains a gamma-turn centered on Thr4, separated by Gly5 from a helical segment that comprises the C-terminal residues.)
  • HY-P2627
    CCK (27-33)

    		Peptides Others
    CCK (27-33) is the C-terminal heptapeptide of cholecystokinin (CCK) .
  • HY-P2592
    Ro 23-7014

    		Peptides Others
    Ro 23-7014 is an appetite suppressant. Ro 23-7014 is an analog of cholecystokinin (CCK-7) .
  • HY-P1097
    Gastrin I, human
    2 Publications Verification

    		 Cholecystokinin Receptor Endocrinology
    Gastrin I, human is the endogenous peptide produced in the stomach, and increases gastric acid secretion via cholecystokinin 2 (CCK2) receptor.
  • HY-P2165
    N-acetyl CCK-(26-30) amide

    CCK-(26-30) (sulfated)

    		 Cholecystokinin Receptor Neurological Disease
    N-acetyl CCK-(26-30) amide (CCK-(26-30) (sulfated)) is a cholecystokinin (CCK) receptor antagonist .
  • HY-P1800
    Caerulein, desulfated

    		Peptides Metabolic Disease
    Caerulein, desulfated is the desulfurated form of Caerulein. Caerulein is a decapeptide having the same five carboxyl-terminal amino acids as gastrin and cholecystokinin (CCK) .
  • HY-A0190
    Ceruletide
    Maximum Cited Publications
    67 Publications Verification

    Caerulein; Cerulein; FI-6934

    		 Cholecystokinin Receptor Cardiovascular Disease Metabolic Disease Endocrinology
    Ceruletide is a decapeptide and a potent cholecystokinin receptor agonist. Ceruletide is a safe and effective cholecystokinetic agent with a direct spasmogenic effect on the gallbladder muscle and bile ducts .
  • HY-P1800A
    Caerulein, desulfated TFA
    1 Publications Verification

    		 Peptides Metabolic Disease
    Caerulein, desulfated TFA is the desulfurated form of Caerulein. Caerulein is a decapeptide having the same five carboxyl-terminal amino acids as gastrin and cholecystokinin (CCK) .
  • HY-P2671
    [Leu15]-Gastrin I (human)

    		Peptides Others
    [Leu15]-Gastrin I (human) is a peptide. Gastrin exerts its function through G-protein-coupled receptor called the cholecystokinin (CCK) or CCK-B receptor (CCK-BR) .
  • HY-P1537
    Pancreatic Polypeptide, bovine

    		Neuropeptide Y Receptor Metabolic Disease Endocrinology
    Pancreatic Polypeptide, bovine, a 36-amino acid, straight chain polypeptide derived primarily from the pancreas, inhibits secretin- and cholecystokinin-stimulated pancreatic secretion; Pancreatic Polypeptide, bovine acts as an agonist of NPY receptor, with high affinity at NPYR4.
  • HY-P2677
    CCK (26-31) (sulfated)

    		Peptides Metabolic Disease
    CCK (26-31) (sulfated) is the N-terminal fragment of CCK, a peptide hormone found in the gut and brain that stimulates digestion, regulates satiety, and is associated with anxiety .
  • HY-P2678
    CCK (26-31) (non-sulfated)

    		Peptides Metabolic Disease
    CCK (26-31) (non-sulfated) is the N-terminal fragment of CCK, a peptide hormone found in the gut and brain that stimulates digestion, regulates satiety, and is associated with anxiety. CCK (26-31) is also less active in non-sulfated than in sulfated form .
  • HY-P4806
    Perisulfakinin

    		Peptides Neurological Disease
    Perisulfakinin, a satiety signaling neuropeptide, inhibits the activity of central neurons promoting general activity .
  • HY-A0261
    Pentagastrin
    1 Publications Verification

    ICI-50123

    		 Cholecystokinin Receptor Endocrinology Cancer
    Pentagastrin (ICI-50123) is a potent, selective Cholecystokinin B (CCKB) receptor antagonists with IC50 values of 11 nM and 1100 nM for CCKB and CCKA, respectively. Pentagastrin enhances gastric mucosal defense mechanisms against acid and protects the gastric mucosa from experimental injury . .

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: